You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NRAS-Mutated CRC

Showing 1 - 25 of 1,656
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, NSCLC Trial (ELI-002 7P)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +14 more
  • ELI-002 7P
  • (no location specified)
Feb 3, 2023

Metastatic Colorectal Cancer, CRC, KRAS/NRAS Mutation Trial (Onvansertib, FOLFIRI, Bevacizumab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • +2 more
  • (no location specified)
Oct 24, 2023

Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)

Recruiting
  • Minimal Residual Disease
  • +11 more
  • ELI-002 2P
  • Duarte, California
  • +10 more
Jan 18, 2023

RAS Mutation, NRAS Gene Mutation, Melanoma Trial in Phoenix, Newnan, Zion (OKI-179 + binimetinib)

Recruiting
  • RAS Mutation
  • +2 more
  • OKI-179 + binimetinib
  • Phoenix, Arizona
  • +4 more
Sep 22, 2022

NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid Tumors Trial in Belgium, Netherlands, United Kingdom (LNP3794)

Active, not recruiting
  • NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid Tumors
  • Brussels, Belgium
  • +3 more
Dec 24, 2021

Melanoma Trial in Beijing (HL-085)

Recruiting
  • Melanoma
  • Beijing, Beijing, China
  • +1 more
Jan 19, 2022

Advanced Solid Tumor (Phase 1), Pancreatic Adenocarcinoma, Malignant Melanoma (Cutaneous) Trial in United States (IMM-1-104)

Recruiting
  • Advanced Solid Tumor (Phase 1)
  • +4 more
  • Duarte, California
  • +4 more
Feb 2, 2023

Advanced Solid Tumors, EGFR Positive NSCLC, Colorectal Carcinoma Trial in United States (TP-0903)

Active, not recruiting
  • Advanced Solid Tumors
  • +4 more
  • Phoenix, Arizona
  • +15 more
Apr 4, 2022

Malignant Solid Tumor, Ovarian Low Grade Serous Adenocarcinoma, Pancreatic Carcinoma Trial (Binimetinib, Biopsy, Biospecimen

Not yet recruiting
  • Malignant Solid Neoplasm
  • +4 more
  • (no location specified)
Nov 8, 2022

Metastatic Colorectal Cancer Trial in United States (Trastuzumab, Cetuximab, Neratinib)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Anaheim, California
  • +47 more
Mar 28, 2022

Optimize Treatment for Patients With Colorectal Cancer

Recruiting
  • Colorectal Cancer
    • Aalborg, North Denmark Region, Denmark
    • +9 more
    Nov 2, 2022

    Non Small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer Trial in United States (BMF-219)

    Recruiting
    • Non Small Cell Lung Cancer
    • +16 more
    • Goodyear, Arizona
    • +10 more
    Jan 24, 2023

    Metastatic Colorectal Cancer Trial in New York (AZD1775, Irinotecan)

    Completed
    • Metastatic Colorectal Cancer
    • New York, New York
      Laura and Isaac Perlmutter Cancer Center
    Oct 8, 2020

    Metastatic Colorectal Cancer Trial in France (Folfirinox + regorrafenib)

    Active, not recruiting
    • Metastatic Colorectal Cancer
    • Folfirinox + regorrafenib
    • Nice, Alpes-Maritimes, France
    • +3 more
    Jan 16, 2023

    AML, Adult, Refractory AML, Relapsed Adult AML Trial in France (AzaCITIDine Oral Tablet, Xospata)

    Not yet recruiting
    • AML, Adult
    • +4 more
    • Amiens, France
    • +19 more
    Sep 1, 2023

    BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation

    Recruiting
    • Metastatic Colorectal Carcinoma
    • Aschaffenburg, Germany
    • +11 more
    Dec 13, 2020

    Advanced Colorectal Cancer Trial in Hangzhou (Cetuximab Dabrafenib Tislelizumab)

    Not yet recruiting
    • Advanced Colorectal Cancer
    • Cetuximab Dabrafenib Tislelizumab
    • Hangzhou, Zhejing, China
      Zhejiang Cancer Institute & Hospital
    Jul 19, 2023

    Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as

    Completed
    • Colorectal Cancer Metastatic
    • Targeted agent
    • (no location specified)
    Aug 31, 2023

    Solid Tumor, ARID1A Gene Mutation Trial in Greenville (Tazemetostat)

    Suspended
    • Solid Tumor
    • ARID1A Gene Mutation
    • Greenville, South Carolina
      Prisma Health Cancer Institute
    Jan 10, 2023

    NSCLC (NSCLC) Colorectal Cancer (CRC) Pancreatic Ductal Adenocarcinoma Advanced Solid Tumors Trial in Irving, San Antonio,

    Not yet recruiting
    • Non-Small Cell Lung Cancer (NSCLC) Colorectal Cancer (CRC) Pancreatic Ductal Adenocarcinoma Advanced Solid Tumors
    • Assigned interventions
    • Irving, Texas
    • +2 more
    Nov 7, 2023

    Aspirin in Combination With Trametinib and Dabrafenib

    Not yet recruiting
    • NSCLC
    • +4 more
    • Combind asprin with Trametinib and Dabrafenib
    • (no location specified)
    Aug 4, 2023

    Colorectal Cancer, Metastatic Colorectal Cancer Trial in United States (Onvansertib, FOLFIRI, Bevacizumab)

    Recruiting
    • Colorectal Cancer
    • Metastatic Colorectal Cancer
    • Birmingham, Alabama
    • +38 more
    Jan 25, 2023

    Colorectal Cancers With Microsatellite Instability

    Active, not recruiting
    • Colorectal Cancer
    • Microsatellite Instability
      • Poitiers, Vienne, France
      • +13 more
      Aug 19, 2022

      Acute Myeloid Leukemia Trial in United States (Gilteritinib, Midostaurin, Daunorubicin)

      Active, not recruiting
      • Acute Myeloid Leukemia
      • Scottsdale, Arizona
      • +43 more
      Nov 17, 2022

      HER2 Mutation-Related Tumors, HER2 Amplified Solid Tumors Trial in Miami Beach, Kansas City (ARX788)

      Withdrawn
      • HER2 Mutation-Related Tumors
      • HER2 Amplified Solid Tumors
      • Miami Beach, Florida
      • +1 more
      Apr 22, 2022